GlassScriptPhysician profile
Joshua B Kramer
NPI 1942646377
$11,004.91
in general payments reported to CMS, 2019-2025
30 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,366 · 2020: $619 · 2021: $2,439 · 2022: $2,657 · 2023: $2,076 · 2024: $502 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,637 · Travel and Lodging: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,637.33 |
| Travel and Lodging | $1,286.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,128.75 | 2019-2025 | Amplatzer Amulet, Amplatzer Talisman, Perclose Proglide |
| Biotronik INC. | $1,944.45 | 2019 | |
| Edwards Lifesciences Corporation | $1,748.19 | 2020-2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,393.43 | 2020-2023 | Watchman Access System, Watchman Flx, Watchdog |
| Abiomed | $420.66 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $364.85 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $328.16 | 2019-2025 | |
| Angiodynamics, INC. | $308.33 | 2021-2022 | |
| Medtronic, INC. | $270.42 | 2021-2023 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $187.69 | 2020 | |
| Amgen INC. | $149.88 | 2022-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $120.12 | 2023-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $114.27 | 2023 | Ffrct |
| Cardiovascular Systems INC. | $71.58 | 2019 | |
| Merck Sharp & Dohme LLC | $69.17 | 2022-2024 | Verquvo, Winrevair |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $63.89 | 2022-2025 | Angio-Seal, Glidewire, Tr Band |
| Irhythm Technologies, INC. | $56.39 | 2023-2024 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $44.75 | 2023-2024 | |
| Masimo Corporation | $25.06 | 2025 | Set and Rainbow Set |
| Eagle Pharmaceuticals, INC. | $24.97 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $23.65 | 2021-2022 | |
| Teleflex LLC | $21.09 | 2023 | Vascband |
| Daiichi Sankyo INC. | $18.33 | 2025 | Injectafer |
| Alnylam Pharmaceuticals INC. | $17.80 | 2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $16.72 | 2024 | Opsumit, Uptravi |
| Novo Nordisk INC | $16.52 | 2021 | |
| Shockwave Medical, INC | $16.26 | 2021 | |
| Philips North America LLC | $14.07 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $13.42 | 2023 | Inpefa |
| Atricure, INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.